Laboratory Interpretation in a 50-Year-Old Woman with Palpitations and Perimenopausal Symptoms
Begin with TSH measurement as the primary screening test, and if TSH is normal (0.45-4.5 mIU/L), thyroid dysfunction is effectively ruled out as the cause of her palpitations 1.
Algorithmic Approach to Lab Interpretation
Step 1: Thyroid Function Assessment (Priority)
TSH is the single most important test because thyroid dysfunction—particularly hyperthyroidism—can cause palpitations and tachycardia up to 114 bpm, and untreated thyrotoxicosis leads to atrial fibrillation, embolic events, and cardiovascular collapse 1.
If TSH < 0.01 mIU/L (undetectable): Measure free T4 and total T3 immediately. Overt hyperthyroidism shows elevated T4 and/or T3. This requires urgent treatment to prevent cardiovascular complications including atrial fibrillation 1.
If TSH 0.1-0.45 mIU/L: Repeat TSH with free T4 and T3 within 2 weeks given her cardiac symptoms (tachycardia to 114 bpm). If persistently low with normal thyroid hormones, this represents subclinical hyperthyroidism requiring 3-12 month monitoring 2.
If TSH normal (0.45-4.5 mIU/L): The patient is almost never hyperthyroid in the absence of TSH-producing pituitary adenoma or thyroid hormone resistance 1. Thyroid dysfunction is excluded as the cause of palpitations.
If TSH > 4.5 mIU/L: Measure free T4. Elevated TSH with normal free T4 indicates subclinical hypothyroidism, which does not cause tachycardia or palpitations but may coexist 3.
Step 2: Complete Blood Count Interpretation
Hemoglobin/Hematocrit: Anemia can cause compensatory tachycardia and palpitations. Values < 12 g/dL in women warrant investigation and treatment.
White blood cell count: Infection or inflammatory processes can cause sinus tachycardia.
Step 3: Basic Metabolic Panel Assessment
Potassium: Hypokalemia (< 3.5 mEq/L) causes cardiac arrhythmias and palpitations.
Calcium: Hypercalcemia (> 10.5 mg/dL) can cause cardiac arrhythmias.
Glucose: Hypoglycemia triggers catecholamine release causing palpitations and tachycardia.
Creatinine: Assess renal function as baseline, though unlikely to cause palpitations directly.
Step 4: Perimenopausal Hormone Panel Interpretation
Perimenopausal hormone testing has limited clinical utility for managing palpitations because:
FSH and estradiol fluctuate dramatically during perimenopause, making single measurements unreliable for diagnosis 4, 5. FSH > 25-30 IU/L with low estradiol (< 20 pg/mL) suggests menopause, but this does not change management of palpitations.
Hot flashes and vasomotor symptoms occur in 75% of perimenopausal women and are diagnosed clinically, not by hormone levels 4.
Palpitations during perimenopause are common but are not directly caused by estrogen deficiency. They result from autonomic instability and increased catecholamine sensitivity 4.
Critical Pitfalls to Avoid
Biotin Interference
Ask specifically about biotin or supplement use (especially those marketed for hair/skin/nails containing 100-fold the recommended daily intake). Biotin causes falsely low TSH in sandwich immunoassays and falsely elevated testosterone/cortisol in competitive assays 6. Discontinue biotin for 2 weeks before retesting if interference is suspected.
Iodine-Containing Supplements
A recent case report 7 documented transient thyrotoxicosis from menopausal supplements containing iodine. Obtain detailed supplement history, particularly given her concern about hormonal impacts and hot flashes.
Heterophile Antibody Interference
Can cause falsely low TSH mimicking hyperthyroidism 8. Suspect if TSH and free T4 results are discordant with clinical picture. Request laboratory perform dilution studies or use alternative assay method.
Thyroid Binding Globulin Abnormalities
Estrogen (including perimenopausal fluctuations) increases TBG, elevating total T4 and T3 while free hormone levels remain normal 1. Always interpret free T4, not total T4, in this population.
Clinical Integration
If TSH is normal, focus investigation away from thyroid disease toward:
Cardiac evaluation: Her heart rate spikes to 114 bpm warrant ECG and possibly Holter monitoring to exclude paroxysmal supraventricular tachycardia or atrial fibrillation.
Autonomic dysfunction: Perimenopausal women experience increased sympathetic tone causing palpitations independent of hormone levels 4.
Anxiety/panic disorder: Though she denies significant anxiety, consider given the episodic nature and association with hot flashes.
Anemia or electrolyte disturbances: Identified through CBC and BMP.
The perimenopausal hormone panel will not explain her palpitations but may guide decisions about menopausal hormone therapy for her hot flashes if they are severe and affecting quality of life 4. However, hormone therapy is not indicated for palpitations alone and carries cardiovascular risks in women with existing cardiac symptoms.